Search Bar & Filters
Found 7 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating whether D-serine, a co-agonist of the N-methyl-D-aspartate receptor NMDAR, can improve symptoms and slow progression in Parkinsons disease PD. This randomized, double-blind, placebo-controlled trial involves 100 participants diagnosed with PD within the past 5 years. The study aims to measure changes in clinical severity using the Movement Disorder Society Unified Parkinsons Disease Rating Scale MDS-UPDRS, along with dopaminergic brain activity and cognitive function. Participants will be randomly assigned to two groups that receive both D-serine and placebo during different study periods over 58 weeks. D-serine dosing starts with 2 capsules of 500 mg twice daily in the first week and increases to 4 capsules twice daily thereafter, while placebo capsules are given similarly. After the intervention phase, a 12-week washout period will follow where the study drug is stopped, with a final visit 12 weeks after discontinuation. During the study, participants will undergo clinical evaluations including rating scales and questionnaires, cognitive testing, blood sampling, and dopamine transporter imaging via SPECT scans. Researchers will closely monitor motor and non-motor symptoms, brain dopamine function, and cognitive changes. The trial includes a screening and treatment optimization phase before randomization to ensure stable Parkinsons treatment. This study may provide important insights into D-serines potential effects on Parkinsons disease progression.
Actively Recruiting
Researchers are evaluating an adapted version of Dialectical Behavior Therapy DBT tailored for adults with Autism Spectrum Disorder ASD who experience significant difficulties in emotion regulation. Autism is a lifelong neurodevelopmental condition that varies widely among individuals, often accompanied by mental health challenges such as anxiety, depression, and self-harm behaviors. This study aims to assess the feasibility, acceptance, and perceived usefulness of this adapted DBT program to help participants improve their emotion regulation, relationships, and ability to avoid crises. The treatment involves a group DBT skills training program adjusted to meet the specific learning needs of autistic adults. The intervention includes 2-3 orientation sessions with a therapist, followed by 28 weekly two-hour skills training sessions, a mid-training evaluation, and a final summary session focusing on goals and problem-solving. Groups consist of approximately 4-6 participants and are led by two DBT therapists. Adjustments include simplified skills with more visuals, autism-relevant examples, hands-on training, and accommodations for sensory sensitivities. Participants will be assessed before and after the 28-week treatment using various tools including the Difficulties in Emotion Regulation Scale DERS, participation tracking, and the DBT Ways of Coping Checklist. Additional assessments include diary cards and qualitative interviews about experiences with the training. Researchers will monitor dropout rates, session attendance, homework completion, and participants use of helpful or unhelpful strategies. The study duration for each participant is approximately 28 weeks, aiming to provide valuable insights into treatment access and effectiveness for autistic adults with emotion regulation challenges.
Actively Recruiting
Researchers are studying patients with diabetic foot ulcers to see if a new treatment using custom felt relief can shorten the healing time compared to the standard relief treatment. This study is conducted by an interdisciplinary diabetic foot ulcer team at the Surgical Outpatient Clinic, aiming to optimize care for this condition. The goal is to compare how quickly wounds heal with the two different relief methods. Participants receive either custom felt relief, which is adjusted weekly by cutting it in various ways and layers to fit the wound, or the standard relief treatment where felt shaped like a letter U is placed around the wound once a week. The study uses a randomized, parallel design to compare these two procedures over the treatment period. During the study, participants will be monitored for wound healing time, which is measured in weeks and expected to range from 2 to 8 weeks. The process includes weekly adjustments or applications of the felt relief depending on the assigned group. The study excludes patients requiring hospital admission or intravenous antibiotics and those needing vascular surgery. The total participation duration can vary based on wound healing progress.
Actively Recruiting
This research aims to explore the genetic causes related to the development of Amyotrophic Lateral Sclerosis ALS in Norway. The study focuses on individuals diagnosed with probable or definite ALS according to the El-Escorial criteria. Understanding genetic factors may help in better characterizing the disease and its risk factors over time. Participants diagnosed with ALS will be followed through the Norwegian health-care system. After giving informed consent, they will complete a brief questionnaire about their family history and provide a blood sample. These samples, along with clinical information and consent forms, are sent to the Department of Medical Genetics at Telemark Hospital Trust for ongoing genetic analysis throughout the recruitment period. Participants may choose to receive their genetic results as part of a diagnostic process. During the study, participants will be involved in providing blood samples and completing questionnaires. Researchers will analyze genetic data to identify gene frequency, new ALS genes, and genetic risk factors between 2020 and 2030. The study involves observation only, with no additional treatments. Participation includes genetic testing and data collection to better understand ALS genetics, with the study continuing until 2035.
Actively Recruiting
Researchers are evaluating the effects of personalized exercise treatment on dynamic balance and physical function compared to regular follow-up care in adults with rare neuromuscular disorders, specifically Charcot-Marie-Tooth CMT, Facioscapulohumeral Muscular Dystrophy FSHD, and Myotonic Dystrophy Type 1 DM1. The study aims to see if the exercise intervention group experiences greater improvements in dynamic balance and long-term benefits compared to the control group receiving usual care. Participants in the experimental group will undergo a four-month exercise program that starts with a 12-day personalized exercise regimen at a rehabilitation center, followed by a three-month digital intervention, and then a second 12-day personalized exercise program at the rehabilitation center. The control group will continue with their usual care, which includes hospital and community health system appointments as recommended individually. During the study, participants will be assessed at baseline, 4 months, 10 months, and 16 months for dynamic balance using the Mini-Balance Evaluation Systems Test Mini-BESTest and other measures such as fatigue severity, strength and function, metabolomics, body composition via Dual Energy X-ray Absorptiometry, neuromuscular ultrasound, physical activity, motor unit number estimation, and health-related quality of life questionnaires. The study involves 120 individuals and includes long-term follow-up for the intervention group to monitor sustained effects.
Actively Recruiting
Knee osteoarthritis is a common condition often treated first with non-surgical methods such as exercise. Despite advances in surgery, about 20% of patients who undergo total knee replacement remain dissatisfied with their results. This trial aims to see if doing strength training before surgery can improve leg strength and reduce dissatisfaction after the operation. Participants will be randomly assigned to one of two groups one group will do maximal leg press strength training three times a week at about 85% of their maximum effort for eight weeks before surgery, and the other will receive usual care without the added training. This setup allows researchers to compare the effects of pre-surgery strength training against standard treatment. Throughout the study, leg strength will be measured at multiple points including before surgery, one week before surgery, three weeks after surgery, and up to 12 months post-surgery. The study will also assess patient satisfaction after surgery, along with voluntary muscle activation, knee function, walking speed, chair rising ability, and balance. These evaluations will help determine if pre-surgery training improves recovery and satisfaction over time.
Actively Recruiting
Researchers are conducting an observational study to understand how new immunotherapies are used in treating multiple myeloma and related conditions in Norway. The study aims to fill knowledge gaps, provide evidence for future trials, and help develop guidelines for monitoring and managing side effects to improve patient survival and quality of life. This research focuses on patients with multiple myeloma, primary plasma cell leukemia, and AL amyloidosis. Participants are observed while receiving immunotherapies including Teclistamab, Elranatamab, Talquetamab, Idecabtagene vicleucel, and Ciltacabtagene Autoleucel as part of their routine care outside of clinical trials. The study monitors how these treatments are used in real-world settings, including dosing and administration. There is no assigned treatment group or placebo instead, the study collects data on treatments given during regular healthcare. Throughout the study, participants response to treatment, progression-free survival, time to next treatment, overall survival, and adverse events are tracked for up to ten years. Researchers collect data on infections, antibiotic resistance, airway viruses, and use of antimicrobial prophylaxis during therapy. This long-term monitoring aims to provide comprehensive safety and effectiveness information to guide future care and research.